Working... Menu

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01423123
Recruitment Status : Completed
First Posted : August 25, 2011
Last Update Posted : July 8, 2014
Information provided by (Responsible Party):
NSABP Foundation Inc